We advise on the most complex, transformative deals
In recent years we have helped our clients transform their businesses and reshape their markets.
Many of the lawyers in our team have scientific backgrounds and have worked in the industry for years.
We offer clients a genuine interest and deep understanding of the sector, combined with integrated and dedicated advice to achieve clients’ objectives.
Our clients include companies active in pharmaceuticals, biotechnology, medical devices and pharmaceutical distribution, as well as other organisations such as healthcare providers, regulatory authorities and academic institutions.
We help our clients address a wide range of issues across the broad health sector, whether looking at legacy products, cutting-edge research and development or reorganisation of businesses, including:
- regulatory support
- licensing deals
- intellectual property (IP) input of transactions and litigation
- M&A, joint ventures, partnership agreements and licensing deals
- sales and distribution strategies
- litigation risks.
- We offer clients worldwide support from a broad and fully-integrated legal team, drawn from corporate, antitrust, IP, regulatory, litigation and product liability groups.
We also provide tax, employment and environmental support for clients.
Paul Humphreys Partner
Doru Gavril Partner
Boris Feldman Partner, Head of U.S. Technology
Aimen Mir Partner
Mary Lehner Partner
Eric Mahr Joint Head – Global Antitrust Litigation Group
Maj Vaseghi Partner
Richard Bird Partner
Andrew Austin Partner
Peter D. Lyons Senior Counsel
Dr. Jochen Dieselhorst Partner
Marcel Kaufmann Partner
Dr. Frank-Erich Hufnagel Partner
Julian Long Partner
Simon Priddis Partner
Gwen Senlanne Partner
Dr. Heiner Braun Partner
Frankfurt am Main
Dr. Michael Ramb Partner